Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.020
0.00 (0.00%)
Nov 6, 2026, 12:57 PM CET
Arterra Bioscience Market Cap
Arterra Bioscience has a market cap or net worth of €20.11 million as of November 6, 2026. It is the 35,829th most valuable company in the world and the 267th biggest in Italy. Its market cap has decreased by 0.66% in one year.
Market Cap
20.11M
Enterprise Value
19.04M
Revenue
5.20M
Global Rank
Country Rank
#267 Italy
PE Ratio
12.09
ChartMarket Cap Chart
Since October 28, 2019, Arterra Bioscience's market cap has decreased from 22.33M to 20.11M, a decrease of -9.94%. That is a compound annual growth rate of -1.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 20.11M | - |
| Dec 30, 2025 | 20.11M | 54.08% |
| Dec 30, 2024 | 13.05M | 18.07% |
| Dec 29, 2023 | 11.05M | -23.15% |
| Dec 30, 2022 | 14.38M | -24.57% |
| Dec 30, 2021 | 19.07M | 1.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.84B |
| DiaSorin | 4.02B |
| Amplifon | 3.23B |
| EL.En. | 1.29B |
| GPI S.p.A. | 435.64M |
| Svas Biosana | 41.78M |
| Talea Group | 40.74M |
| Helyx Industries | 16.13M |